Effects of levodopa on upper limb mobility and gait in Parkinson’s disease

Background: Most clinicians rely on clinical scales such as the unified Parkinson’s disease rating scale (UDPRS) for evaluating parkinsonian patients and assessing their response to levodopa. Gait analysis is not commonly used, probably because of the equipment required and the time needed. Few data have been published on the relations between gait variables and measures of arm and hand mobility. Objectives: To evaluate the correlation between dopa induced gait improvement and upper limb motor improvement using a rapid and simple method; and to evaluate the correlation between gait improvement and UPDRS III improvement. Methods: A finger tapping test and a simple walking test were used to measure the OFF-ON variations of upper limb motor function and gait in 23 patients with Parkinson’s disease. The UPDRS motor score and the Hoehn and Yahr stage were measured in the OFF and the ON state. Results: There was no correlation between OFF-ON variation of the number of hits with the finger tapping test and OFF-ON variation in the gait variables. OFF-ON variation in the UPDRS motor score was not correlated with OFF-ON variation in the gait variables. Conclusions: There was a dissociation between the effect of levodopa on upper limb and gait. The findings suggest that simple measures like the finger tapping test and a walking test should be included in the usual evaluation of patients with Parkinson’s disease.

[1]  Hiroshi Mitoma,et al.  Characteristics of parkinsonian and ataxic gaits: a study using surface electromyograms, angular displacements and floor reaction forces , 2000, Journal of the Neurological Sciences.

[2]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[3]  R. Dunnewold,et al.  Quantitative assessment of bradykinesia in patients with parkinson's disease , 1997, Journal of Neuroscience Methods.

[4]  L. Defebvre,et al.  Effect of thalamic stimulation on gait in Parkinson disease. , 1996, Archives of neurology.

[5]  J. Pailhous,et al.  Dopa-sensitive and Dopa-resistant gait parameters in Parkinson's disease , 1991, Journal of the Neurological Sciences.

[6]  J. Summers,et al.  The pathogenesis of gait hypokinesia in Parkinson's disease. , 1994, Brain : a journal of neurology.

[7]  R. Dobbs,et al.  Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia. , 1991, British journal of clinical pharmacology.

[8]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[9]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[10]  P. Vieregge,et al.  Gait quantitation in Parkinson's disease — locomotor disability and correlation to clinical rating scales , 2005, Journal of Neural Transmission.

[11]  E. Tolosa,et al.  Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. , 1999, Brain : a journal of neurology.

[12]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[13]  J. Pailhous,et al.  [A new method of quantitative analysis of parkinsonian gait: report of 6 patients]. , 1990, Revue neurologique.

[14]  A. Hughes,et al.  Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function , 1998, Movement disorders : official journal of the Movement Disorder Society.

[15]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .